Search research articles
Contact Us
Filters
Showing results (51-60 of 57) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 57 results.
Vaccines
|
October 26, 2021
Novel Recombinant Newcastle Disease Virus-Based <i>In Ovo</i> Vaccines Bypass Maternal Immunity to Provide Full Protection from Early Virulent Challenge
Kiril M Dimitrov, Tonya L Taylor, Valerie C Marcano, et al.
Journal of Medical Virology
|
August 12, 2020
The recombinant Newcastle disease virus Anhinga strain expressing human TRAIL exhibit antitumor effects on a glioma nude mice model
Jinjiao He, Ying An, Jianying Qi, et al.
The Journal of General Virology
|
January 29, 2015
Development of a novel thermostable Newcastle disease virus vaccine vector for expression of a heterologous gene
Guoyuan Wen, Chen Chen, Jing Guo, et al.
Gene Therapy
|
May 16, 2020
Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses
Tianyan Liu, Yu Zhang, Yukai Cao, et al.
Journal of Virology
|
May 14, 2004
Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro
Matthew B Elliott, Karin S Pryharski, Qingzhong Yu, et al.
Journal of Virology
|
July 29, 2004
Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein
Matthew B Elliott, Karin S Pryharski, Qingzhong Yu, et al.
Plos Pathogens
|
June 9, 2022
Quantitative regulation of the thermal stability of enveloped virus vaccines by surface charge engineering to prevent the self-aggregation of attachment glycoproteins
Yu Shang, Li Li, Tengfei Zhang, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 57) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 57 results.
Vaccines
|
October 26, 2021
Novel Recombinant Newcastle Disease Virus-Based <i>In Ovo</i> Vaccines Bypass Maternal Immunity to Provide Full Protection from Early Virulent Challenge
Kiril M Dimitrov, Tonya L Taylor, Valerie C Marcano, et al.
Journal of Medical Virology
|
August 12, 2020
The recombinant Newcastle disease virus Anhinga strain expressing human TRAIL exhibit antitumor effects on a glioma nude mice model
Jinjiao He, Ying An, Jianying Qi, et al.
The Journal of General Virology
|
January 29, 2015
Development of a novel thermostable Newcastle disease virus vaccine vector for expression of a heterologous gene
Guoyuan Wen, Chen Chen, Jing Guo, et al.
Gene Therapy
|
May 16, 2020
Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses
Tianyan Liu, Yu Zhang, Yukai Cao, et al.
Journal of Virology
|
May 14, 2004
Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro
Matthew B Elliott, Karin S Pryharski, Qingzhong Yu, et al.
Journal of Virology
|
July 29, 2004
Characterization of recombinant respiratory syncytial viruses with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein
Matthew B Elliott, Karin S Pryharski, Qingzhong Yu, et al.
Plos Pathogens
|
June 9, 2022
Quantitative regulation of the thermal stability of enveloped virus vaccines by surface charge engineering to prevent the self-aggregation of attachment glycoproteins
Yu Shang, Li Li, Tengfei Zhang, et al.
Page
of 6